Post Pandemic Pneumococcal Carriage Among Children and Adults
NCT06373328 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 900
Last updated 2024-12-06
Summary
The PI propose to conduct a genomic epidemiology study of pneumococcal carriage among children and adults in a large metropolitan city. These data will allow PI to assess the post-pandemic population structure, investigate the phylogenetic relationship between isolates from children and adults, and compare pneumococcal populations across diverse geographic areas.
Conditions
- Pneumococcal Carriage
Sponsors & Collaborators
-
Merck Sharp & Dohme Corporation
collaborator UNKNOWN -
University of Central Florida
lead OTHER
Principal Investigators
-
Taj Azarian, PhD · University of Central Florida
Eligibility
- Min Age
- 7 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-06-12
- Primary Completion
- 2025-09-30
- Completion
- 2026-03-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Learn About How a New Pneumococcal Vaccine Works in Adults
NCT07086677 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage
NCT00294021 ·Status: COMPLETED
-
Understanding Pneumococcal Carriage and Disease 2017-2020
NCT03102840 ·Status: UNKNOWN
-
Understanding Pneumococcal Carriage and Disease
NCT01996007 ·Status: COMPLETED
-
Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.
NCT04583618 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
NCT06531538 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population
NCT00307528 ·Status: COMPLETED ·Phase: PHASE2
-
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
NCT07135453 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults
NCT06182124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants
NCT04382326 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults
NCT03828617 ·Status: COMPLETED ·Phase: PHASE3
-
Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)
NCT00560950 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants
NCT03512288 ·Status: COMPLETED ·Phase: PHASE2
-
Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT07035054 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population
NCT00327665 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine
NCT00345358 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age
NCT03313050 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects
NCT00500266 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001)
NCT04168190 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pneumoniae Epidemiology Study in China
NCT00471770 ·Status: COMPLETED
-
A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60
NCT06970756 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine
NCT00370227 ·Status: COMPLETED ·Phase: PHASE3
-
Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination
NCT00143780 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Pneumococcal Vaccine Formulations in Young Adults
NCT00707798 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years
NCT02955160 ·Status: COMPLETED ·Phase: PHASE1